Most Recent
Epic Games hearing to go ahead despite Google settlement
A hearing on the relief Fortnite maker Epic Games is entitled to in its successful competition case against Google and Apple could be affected by a hearing on a worldwide settlement reached by Google, a judge has said.
Construction PRO
Villawood director can’t bring alternative argument in dispute over $295M property
A director of developer Villawood has lost his bid to bring an alternative claim in his case against the company’s subsidiary alleging he is entitled to part of a property said to be worth $295 million.
Apple wants to rob judgment of ‘bite’ in Epic Games case, court told
Orders proposed by Apple after a judge’s finding that the digital giant and rival Google engaged in anti-competitive conduct would “rob the court’s findings of their detail, their efficacy and their bite”, Epic Games has said.
Construction PRO
ACT warehouse owner loses $5M case over defective flooring
The NSW Court of Appeal has dismissed an appeal launched by a Canberra warehouse owner, which sought over $5.3 million from the previous owner for the cost of replacing a concrete slab.
SkyCity shareholder can’t bring action over $67M AUSTRAC penalty
A SkyCity shareholder has lost his bid to bring a case against former executives and directors at the ASX-listed casino seeking to recoup a $67 million penalty over breaches of money laundering regulations. 
Takeovers Panel says Cosette can’t shutter Mayne’s Adelaide drug plant
The Takeovers Panel has found Cosette cannot close a Mayne Pharma drug manufacturing plant in Adelaide, another win for Mayne in its push to block the US drug maker from walking away from their $672 million merger.
Mayne wins extension of FIRB deadline for Cosette takeover
The Foreign Investment Review Board has extended the deadline for ruling on Cosette's proposed $672 million takeover of Mayne Pharma.
Mayne, Cosette row to be decided on merits after panel resets merger clock
The Takeovers Panel has agreed to hear Mayne Pharma's latest dispute with Cosette over the US drug maker's attempts to walk away from their $672 million merger agreement and extended the timeline for completing the deal.
Mayne wins breathing room in fight to get Cosette merger over the line
Mayne Pharma has secured an extension of the deadline for securing Foreign Investment Review Board approval of its $672 million tie-up with US drug maker Cosette.
Cosette appeals loss over exit from $672M Mayne Pharma merger
Cosette plans to appeal a ruling that rejected its bid to terminate an agreement to merge with Mayne Pharma, as the US drug company also refuses to agree to conditions needed to win Foreign Investment Review Board approval for the tie-up.